Last $1.70 USD
Change Today -0.02 / -1.16%
Volume 53.7K
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

intermolecular inc (IMI) Snapshot

Open
$1.76
Previous Close
$1.72
Day High
$1.76
Day Low
$1.67
52 Week High
05/19/14 - $3.45
52 Week Low
02/6/15 - $1.55
Market Cap
82.2M
Average Volume 10 Days
119.7K
EPS TTM
$-0.44
Shares Outstanding
48.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INTERMOLECULAR INC (IMI)

intermolecular inc (IMI) Related Bloomberg News

View More Bloomberg News

intermolecular inc (IMI) Related Businessweek News

No Related Businessweek News Found

intermolecular inc (IMI) Details

Intermolecular, Inc. develops and applies high productivity combinatorial (HPC) research and development technologies for the semiconductor and clean energy industries. Its HPC platform includes wet processing tools that apply HPC methods to fluids-based applications, such as cleans, deposition and wet etch, self-assembly, and surface treatment processes; and dry processing tools, which apply HPC methods to vapor-based applications for primary, secondary, and tertiary screening. The company’s HPC platform also comprise automated characterization systems to characterize the substrates processed by Tempus HPC processing tools and generates experimental data while matching processing throughput; and informatics software comprising workflow management software, analysis and reporting software, security and collaboration management software, and integration services. It serves semiconductor device, semiconductor materials and equipment, and clean-energy companies in the United States, Japan, Europe, the Middle East, and the APAC. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.

intermolecular inc (IMI) Top Compensated Officers

Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $73.7K
Senior Vice President of Customer CDPs
Total Annual Compensation: $300.4K
Vice-President of Finance and Corporate Contr...
Total Annual Compensation: $239.6K
Consultant and Member of Scientific Advisory ...
Total Annual Compensation: $214.9K
Compensation as of Fiscal Year 2013.

intermolecular inc (IMI) Key Developments

Intermolecular Mulls Acquisitions

Intermolecular, Inc. (NasdaqGS:IMI) seeks to invest in or acquire complementary businesses, applications or technologies, any of which could also require to seek additional equity or debt financing.

Intermolecular, Inc. Announces Unaudited Consolidated Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2014; Provides Revenue Guidance for the First Quarter of 2015

Intermolecular, Inc. announced unaudited consolidated financial results for the fourth quarter and fiscal year ended December 31, 2014. Revenue for the fourth quarter of 2014 was $11.0 million, compared to $15.6 million in the same period a year ago. As reported under GAAP, the company reported a net loss of $6.1 million, or $0.13 per basic and diluted share, for the fourth quarter of 2014, compared to net loss of $4.4 million, or $0.10 per basic and diluted share, for the fourth quarter of 2013. Non-GAAP net loss for the fourth quarter of 2014 was $4.6 million, or $0.10 per basic and diluted share. This compared with a non-GAAP net loss of $3.0 million, or $0.07 per basic and diluted share, for the fourth quarter of 2013. Operating loss was $5,922,000 compared to $4,243,000 a year ago. Loss before provision for income taxes was $6,088,000 compared to $4,433,000 a year ago. Non-GAAP operating loss was $4,430,000 compared to $2,848,000 a year ago. For the year ended December 31, 2014, revenue was $47.7 million compared to revenue of $67.4 million in 2013. Net loss for 2014 was $21.8 million, or $0.47 per basic and diluted share, compared with a net loss of $8.8 million, or $0.20 per basic and diluted share, for 2013. Non-GAAP net loss for the year ended December 31, 2014 was $14.4 million, or $0.31 per basic and diluted share. This compared with non-GAAP net loss of $3.3 million, or $0.07 per basic and diluted share, for 2013. Operating loss was $21,043,000 compared to $8,029,000 a year ago. Loss before provision for income taxes was $21,754,000 compared to $8,802,000 a year ago. Non-GAAP operating loss was $13,661,000 compared to $2,546,000 a year ago. Net cash used in operating activities was $1,850,000 compared to $7,779,000 a year ago. Purchase of property and equipment was $2,815,000 compared to $13,534,000 a year ago. Capitalized intangible assets was $1,194,000 compared to $1,585,000 a year ago. For the first quarter of 2015, the company projects revenue in the range of $9.0 to $10.0 million. This revenue projection includes approximately $8.4 million from reported backlog as of December 31, 2014.

Intermolecular, Inc. to Report Q4, 2014 Results on Feb 12, 2015

Intermolecular, Inc. announced that they will report Q4, 2014 results at 5:00 PM, US Eastern Standard Time on Feb 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMI:US $1.70 USD -0.02

IMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMI.
View Industry Companies
 

Industry Analysis

IMI

Industry Average

Valuation IMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.7x
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERMOLECULAR INC, please visit www.intermolecular.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.